Incorporating anti-Ro/SSA and anti-La/SSB autoantibody testing into infertility screening and multidisciplinary counseling within IVF protocols permits earlier risk identification, improved prenatal surveillance, and informed planning for future pregnancies. This evidence concerns the gene TRIM21 and Infertility.